Loyal, a company developing treatments for longevity in dogs, recently announced that they have "completed the technical effectiveness portion of their conditional approval for [their first drug candidate]".

Will they successfully establish safety of LOY-001 (according to the FDA)? Resolves NO if they fail for any reason, including, for example, running out of money before they complete their studies.